Kairos Pharma Ltd. (KAPA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kairos Pharma Ltd.

    AMEX: KAPA · Real-Time Price · USD
    1.12
    -0.07 (-6.28%)
    At close: Sep 25, 2025, 3:59 PM
    1.13
    0.89%
    After-hours: Sep 25, 2025, 07:27 PM EDT

    Kairos Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 160K 160K 160K 98K
    Gross Profit
    		 -160K -160K -160K -98K
    Operating Income
    		 -2.34M -1.71M -571K -1.94M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -2.6M -1.81M -1.05M -2.15M
    Net Income
    		 -2.6M -1.81M -1.05M -2.15M
    Selling & General & Admin
    		 1.93M 1.47M 324K 1.66M
    Research & Development
    		 414K 82K 87K 183K
    Other Expenses
    		 n/a 160K 160K 98K
    Operating Expenses
    		 2.34M 1.71M 571K 1.94M
    Interest Expense
    		 859K 98K 479K 202K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -2.34M 1.71M 571K 1.94M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 11.36M 10.38M 10.24M 12.84M
    Shares Outstanding (Diluted)
    		 11.36M 10.38M 10.24M 12.84M
    EPS (Basic)
    		 -0.23 -0.17 -0.1 -0.17
    EPS (Diluted)
    		 -0.23 -0.17 -0.1 -0.17
    EBITDA
    		 -2.34M -1.55M -431K -1.88M
    EBIT
    		 -2.64M -1.71M -591K -1.98M
    Depreciation & Amortization
    		 295K 160K 160K 98K

    Add to Watchlist